T3 dosing is not a one-size-fits-all number. Most people prescribed synthetic T3 (liothyronine) for hypothyroidism start at 5 micrograms per day and work up slowly, with typical maintenance doses falling somewhere between 5 and 25 mcg daily depending on whether T3 is used alone or alongside T4 (levothyroxine). The dose your doctor settles on depends on a surprisingly long list of variables, from your lean body mass and age to your genetics and how your body handles the drug’s sharp peaks in blood levels.
How Your Body Normally Produces T3
To understand why T3 dosing gets complicated, it helps to know how much T3 your body makes on its own. A healthy thyroid gland secretes roughly 85 mcg of T4 and about 6.5 mcg of T3 each day, giving a secretion ratio of around 13 to 1 in favor of T4.1Frontiers in Endocrinology. Can Reverse T3 Assay Be Employed to Guide T4 vs. T4/T3 Therapy in Hypothyroidism? – Section: Thyroid Physiology—Deiodinases But that 6.5 mcg from the thyroid is only part of the picture. Most of the T3 circulating in your blood actually comes from T4 being converted in tissues throughout the body, particularly in the liver and kidneys. A detailed kinetic study in healthy volunteers found that the thyroid contributed about 3.3 mcg per square meter of body surface per day, while peripheral conversion added about 12.7 mcg per square meter per day, meaning roughly 80 percent of your circulating T3 is made outside the thyroid.2PubMed. Thyroidal and peripheral production of 3,5,3′-triiodothyronine in humans by multicompartmental analysis
This matters because when you take levothyroxine (T4) alone, you are relying entirely on that conversion process to generate your T3. For most people that works fine. But for a subset of patients, conversion seems insufficient, and that is where adding T3 directly enters the picture.
Why T3 Dosing Is Not Straightforward
T3 is a much more potent hormone than T4 and acts faster. When you swallow a liothyronine tablet, blood levels of T3 begin climbing within about 45 minutes, peak at roughly two and a half hours, and then decline with a half-life of about 22 to 23 hours.3PubMed Central. Single Dose T3 Administration: Kinetics and Effects on Biochemical and Physiologic Parameters – Section: RESULTS A separate pharmacokinetic study confirmed a similar pattern: peak concentration at about 1.8 hours, followed by a fast initial distribution phase and a slower elimination phase with a half-life of roughly 23 hours.4PubMed Central. Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal – Section: Results
That sharp spike is the central challenge with T3 dosing. In one study, participants taking a once-daily dose of liothyronine saw their T3 levels surge to an average peak of about 293 ng/dL after dosing, while their pre-dose trough levels hovered around 92 to 100 ng/dL. The study concluded that once-daily therapy produces significant excursions in both total and free T3 levels, and that combination therapy trials using standard liothyronine tablets would face similar swings, even if somewhat smaller in magnitude.5PubMed Central. Daily Administration of Short-Acting Liothyronine Is Associated with Significant Triiodothyronine Excursions and Fails to Alter Thyroid-Responsive Parameters – Section: CONCLUSIONS Those peaks can push T3 temporarily into the hyperthyroid range, even when the overall daily dose is reasonable. This is why many clinicians split the dose, giving you 5 mcg two or three times a day rather than 10 or 15 mcg all at once.
Combination Therapy and the Ratio Question
Most people who take T3 do not take it alone. They take it alongside levothyroxine, an approach called combination therapy. The key question then becomes what ratio of T4 to T3 best mimics healthy physiology. This is where things get debated. Clinical trials have tested ratios of 5:1 and 10:1 (T4 to T3), comparing them with T4-only treatment.6The Journal of Clinical Endocrinology & Metabolism. Combined Therapy with Levothyroxine and Liothyronine in Two Ratios, Compared with Levothyroxine Monotherapy in Primary Hypothyroidism: a Double-Blind, Randomized, Controlled Clinical Trial The natural secretion ratio of the thyroid is roughly 13:1, but some practitioners argue the physiologically appropriate ratio for replacement therapy should be closer to the 11:1 figure cited in major pharmacology references.7PubMed. Bioidentical thyroid replacement therapy in practice: Delivering a physiologic T4:T3 ratio for improved patient outcomes with the Listecki-Snyder protocol
Despite an initial burst of enthusiasm in the early 2000s, subsequent clinical trials have generally not confirmed a clear advantage of combination therapy over T4 alone for most patients. A review of the evidence noted that later studies using both substitution protocols and fixed-combination approaches, including those based on the physiological T4-to-T3 secretion ratio, did not replicate the early positive results.8The Journal of Clinical Endocrinology & Metabolism. Treatment of Hypothyroidism with Combinations of Levothyroxine plus Liothyronine – Section: Abstract That does not mean combination therapy is useless. It means the evidence for broad benefit is weaker than many patients assume, and that the patients who do benefit may be a specific subgroup rather than everyone on thyroid medication.
Desiccated Thyroid Extract and Its Built-In Ratio
Desiccated thyroid extract (DTE), sold under brand names like Armour Thyroid or Nature-Throid, is derived from pig thyroid glands and contains both T4 and T3 in a fixed ratio of about 4:1. This ratio delivers more T3 relative to T4 than either the human thyroid secretes or most combination therapy protocols provide. A review of DTE use found that the average daily dose needed to normalize TSH levels contains roughly 11 mcg of T3, though some patients require higher amounts.9PubMed Central. Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism – Section: Summary
DTE dominated thyroid treatment for most of the 20th century. Two developments in the 1970s pushed it aside: the introduction of TSH blood testing revealed that many patients on DTE were being overtreated, and the discovery that the body converts T4 to T3 on its own gave doctors a rationale for prescribing T4 alone.10PubMed Central. The History and Future of Treatment of Hypothyroidism – Section: Abstract Even so, DTE remains popular with patients who feel better on it than on levothyroxine alone, and some endocrinologists still prescribe it. The higher T3 content does mean a greater risk of those same blood-level spikes, and the 4:1 ratio cannot be adjusted without switching to separate T4 and T3 tablets.
What Determines Your Personal Dose
When your doctor chooses a starting dose and adjusts it upward, they are considering several factors that vary widely from person to person.
Lean body mass is one of the strongest predictors of how much thyroid hormone you need. Research has consistently shown that the dose of levothyroxine correlates much more tightly with lean mass than with total body weight or fat mass. One study found a strong association between levothyroxine dose and lean body mass, while the correlation with fat mass was weak. Peripheral lean mass, meaning muscle and organ tissue in the arms and legs, was the single best predictor.11PubMed. Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases An earlier study in older adults reached the same conclusion, noting that the age-related decline in lean mass likely explains why older people generally need lower doses.12PubMed. Lean body mass is a predictor of the daily requirement for thyroid hormone in older men and women Although this research focused on T4 dosing, the principle extends to T3 as well: a larger, more muscular person has more tissue that metabolizes thyroid hormone and generally needs more of it.
Age matters partly because of that lean-mass effect, but also because older adults tend to be more sensitive to the cardiovascular effects of thyroid hormones. Clinicians typically start elderly patients on the lowest possible dose and increase very slowly, often in increments of 2.5 mcg. If you are over 65 or have heart disease, your doctor will be especially cautious.
The cause of your hypothyroidism also plays a role. Someone who has had their thyroid completely removed after cancer produces zero thyroid hormone of any kind and generally needs higher replacement doses than someone whose thyroid is merely underperforming due to Hashimoto’s disease. Patients on TSH-suppressive therapy after thyroid cancer are a special case; their dosing is deliberately pushed higher to keep TSH very low, which brings its own risks.
Genetics and Why Some People Respond Differently
One of the more interesting developments in thyroid medicine is the growing evidence that genetic variation affects how well you convert T4 to T3 and how much benefit you get from adding T3 to your regimen. A common variant in the DIO2 gene (called Thr92Ala) reduces the activity of the enzyme responsible for converting T4 to T3 in tissues. Researchers found that thyroid-deficient patients carrying one or two copies of this variant had significantly lower free T3 levels after thyroid surgery, whereas patients without the variant maintained nearly normal T3 levels on T4 therapy alone.13The Journal of Clinical Endocrinology & Metabolism. DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients – Section: Results
Another study took this further by looking at two genetic variants together: one in DIO2 and one in MCT10, a gene involved in transporting thyroid hormone into cells. When patients carried both variants, 100 percent preferred the combined T4-plus-T3 treatment over T4 alone. Among patients with just one of the two variants, about 63 percent preferred combination therapy, and among those with neither variant, only 42 percent did.14PubMed Central. Hypothyroid Patients Encoding Combined MCT10 and DIO2 Gene Polymorphisms May Prefer L-T3 + L-T4 Combination Treatment – Data Using a Blind, Randomized, Clinical Study – Section: Results The implication is that genetic testing could eventually help identify who actually needs T3, rather than treating everyone the same way. For now, most doctors do not routinely test for these variants, but it is worth knowing about if you are struggling on T4 monotherapy and wondering whether combination therapy might help.
Risks of Taking Too Much
Because T3 is potent and fast-acting, the margin between a helpful dose and a harmful one is narrower than with T4. The main risks of excess T3 fall into two categories: cardiac and skeletal.
Atrial fibrillation is the heart rhythm disturbance most closely linked to excess thyroid hormone. Up to 15 percent of people with overt hyperthyroidism develop atrial fibrillation, compared with about 4 percent in the general population, and the risk is particularly elevated in men and in patients with T3-driven thyroid excess.15PubMed Central. The mechanisms of atrial fibrillation in hyperthyroidism Even subclinical overtreatment, where your TSH is pushed low but your T3 and T4 levels remain in the “normal” range, raises arrhythmia risk. One review emphasized that clinicians who push levothyroxine doses higher to reach the low end of normal TSH, aiming for better symptom control, are also increasing the risk of atrial fibrillation, and that adding T3 to the mix further complicates that risk.16PubMed Central. Levothyroxine Treatment and the Risk of Cardiac Arrhythmias – Focus on the Patient Submitted to Thyroid Surgery – Section: Abstract
Bone density is the other major concern. Long-term use of thyroid hormone at doses that suppress TSH has been associated with decreased bone mineral density and a potential increase in fracture risk, especially in postmenopausal women.17PubMed Central. Thyroid Hormone Diseases and Osteoporosis The picture is not entirely clear-cut, though. An older cross-sectional study found that vertebral bone density in patients on either replacement or suppressive doses of levothyroxine was not significantly different from age-matched healthy controls.18PubMed. Bone mineral density and thyroid hormone therapy The discrepancy likely reflects differences in how long patients were overtreated and how deeply TSH was suppressed. The safest approach is to use the lowest dose that controls your symptoms without pushing TSH below the normal range, unless you have a specific medical reason (such as thyroid cancer suppression) to do otherwise.
Lab Monitoring on T3 Therapy
Monitoring your blood levels while on T3 is trickier than monitoring T4 therapy. Because liothyronine causes those sharp peaks and slow declines, the timing of your blood draw relative to your last dose matters enormously. If your blood is drawn two hours after you take your pill, your T3 level will be near its peak and will look alarmingly high even if your overall dosing is appropriate. If it is drawn 24 hours after your last dose, you will see only the trough level, which may look low even though your tissues received plenty of hormone earlier in the day.
Most endocrinologists recommend drawing blood before the morning dose, capturing the trough. TSH remains the primary guide for dose adjustments, but because T3 suppresses TSH more acutely than T4 does, a slightly below-normal TSH on combination therapy does not necessarily mean you are overdosed. Your doctor may also check free T3 and free T4 to get a fuller picture. The goal is typically a TSH that remains somewhere in the normal range, with T3 levels that do not swing wildly above the upper limit at peak. If you are experiencing palpitations, tremor, or anxiety a couple of hours after taking your T3, that is a strong signal the peak level is climbing too high, even if your trough blood work looks fine.
T3 for Depression
Outside of hypothyroidism, T3 has been used as an add-on treatment for depression, particularly when antidepressants alone have not worked well enough. The typical dose in this context is 25 to 50 mcg per day, which is higher than most hypothyroid combination therapy regimens. A review of the evidence found that liothyronine is an effective augmentation and enhancement strategy when combined with antidepressants, particularly tricyclic antidepressants and SSRIs, and that with appropriate safety monitoring it can be used safely for unipolar depression.19PubMed Central. Liothyronine for Depression: A Review and Guidance for Safety Monitoring – Section: Abstract
The mechanism behind why extra T3 helps depression is not fully understood. It may involve T3’s effects on serotonin signaling in the brain, or it may simply reflect that some depressed patients have subtle thyroid hormone deficiencies at the tissue level that do not show up on standard blood tests. If your psychiatrist has suggested adding T3 to your antidepressant, the monitoring approach is similar to what endocrinologists use: periodic checks of TSH, free T3, and heart-related symptoms. The cardiac and bone risks described above still apply, so the goal is always the lowest effective dose.
Sustained-Release T3 and What May Be Coming
The spike-and-crash pattern of standard liothyronine is the drug’s biggest limitation. If you could deliver T3 slowly over 24 hours, mimicking the steady drip of T3 that comes from natural conversion in your tissues, many of the dosing headaches would disappear. Researchers have been working on sustained-release T3 formulations for years, and a few have reached clinical testing.
A clinical trial of a combined levothyroxine-plus-sustained-release T3 preparation found that the sustained-release version delayed peak T3 levels to about 4.4 hours (versus the usual 2 to 2.5 hours with standard tablets) and kept serum T3 within a narrow range for up to 24 hours with fluctuations of no more than 25 ng/dL from the mean.20PubMed Central. Pharmacodynamic and pharmacokinetic properties of the combined preparation of levothyroxine plus sustained- release liothyronine; a randomized controlled clinical trial – Section: Results A review of the broader landscape noted that while one slow-release formulation tested in 17 patients did succeed in reducing peak T3 by about 9 percent and pushing the time to peak from roughly 3.2 to 5 hours, a different formulation failed to produce sustained levels at all.21Frontiers in Endocrinology. Sustained Release T3 Therapy: Animal Models and Translational Applications – Section: Delivery Systems That Aim at Physiological Replacement of T3 The technology is promising but inconsistent so far, and no sustained-release T3 product is widely available commercially yet. Some compounding pharmacies offer their own slow-release preparations, but these are not FDA-approved and quality can vary.
If a reliable sustained-release T3 pill reaches the market, it would change the dosing conversation significantly. A single daily dose that avoids supraphysiological peaks would make combination therapy simpler, safer, and easier to study in large trials. For now, though, standard liothyronine tablets remain the only widely accessible option, and split dosing remains the practical workaround for the spike problem.
Practical Tips for Adjusting Your Dose
If you and your doctor have decided to try T3, a few practical details can make the process smoother.
- Start low: Most protocols begin at 5 mcg once daily. After four to six weeks, your doctor checks TSH and free T3 at trough and decides whether to increase.
- Split your doses: Once you go above 5 mcg, taking the total daily amount in two or three divided doses reduces peak-related symptoms like palpitations and jitteriness.
- Time your blood draws: Get labs drawn before your morning dose, ideally at roughly the same time of day each visit, so results are comparable.
- Watch for symptoms, not just numbers: Heart racing, tremor, insomnia, and feeling wired an hour or two after taking your pill suggest the peak is too high, even if your trough labs look acceptable. Fatigue, brain fog, and cold intolerance at the end of the dosing interval suggest you may need a higher total dose or a more frequent dosing schedule.
- Reduce T4 when adding T3: If you were on levothyroxine alone and are adding T3, your T4 dose usually needs to come down to avoid overtreatment. The exact reduction depends on how much T3 you are adding and how your body responds.
Liothyronine tablets are available in 5 mcg and 25 mcg strengths. The 25 mcg tablet can be split, but it is small and crumbles easily, so pill cutters work better than trying to break it by hand. Compounded T3 in custom doses (such as 2.5 mcg or 7.5 mcg capsules) offers more flexibility but at higher cost and without the quality assurance of manufactured tablets.
Medications and Foods That Interfere
Like levothyroxine, liothyronine absorption can be affected by calcium supplements, iron, antacids, and certain other medications if taken at the same time. Spacing T3 at least 30 to 60 minutes away from food and supplements is generally recommended, though T3 is somewhat better absorbed than T4 in the presence of food. Estrogen therapy, whether from birth control pills or hormone replacement, can increase thyroid-binding proteins in the blood and effectively lower the amount of free, active thyroid hormone available. If you start or stop estrogen, your T3 dose may need adjustment. The same applies to medications that speed up or slow down the liver’s metabolism of thyroid hormones, including certain seizure drugs and rifampin.
Biotin supplements deserve special mention, not because they affect your actual thyroid hormone levels, but because high-dose biotin can interfere with the immunoassays used to measure TSH and free T3 in the lab. This can produce falsely low TSH readings and falsely high T3 readings, which might make it look like you are on too much thyroid hormone when you are not. If you take biotin, stop it for at least two to three days before any thyroid blood work.